ProCE Banner Activity

Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: Surgeon Perspective

Slideset Download

Download this slideset to review key data on the use of neoadjuvant immune checkpoint inhibitor–based therapy in resectable early-stage NSCLC from a surgeon’s perspective.

Released: December 01, 2021

Share

Faculty

Jonathan Spicer

Jonathan Spicer, MD, PhD, FRCS

Associate Professor of Surgery
Department of Surgery
McGill University
Medical Director
McGill Thoracic Oncology Network
Attending Thoracic Surgeon
Department of Surgery
McGill University Health Center
Montreal, Quebec, Canada

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group

Faculty Disclosure

Primary Author

Jonathan Spicer, MD, PhD, FRCS

Associate Professor of Surgery
Department of Surgery
McGill University
Medical Director
McGill Thoracic Oncology Network
Attending Thoracic Surgeon
Department of Surgery
McGill University Health Center
Montreal, Quebec, Canada